Voyager Therapeutics, Inc. Share Price
VYGRVoyager Therapeutics, Inc. Stock Performance
Open $4.31 | Prev. Close $4.25 | Circuit Range N/A |
Day Range $4.20 - $4.36 | Year Range $2.65 - $7.44 | Volume 52,188 |
Average Traded $4.26 |
Voyager Therapeutics, Inc. Share Price Chart
About Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. The company's lead product candidate is VY7523, an anti-tau antibody program for the treatment of alzheimer's disease (AD). Its product pipeline includes VY1706, a tau silencing gene therapy in preclinical trial for the treatment of alzheimer's disease; SOD1 silencing gene therapy program for treating amyotrophic lateral sclerosis in preclinical trial; and vectorized anti-amyloid antibody early research program for the treatment of AD in preclinical trial. The company is also developing VY-FXN01 for treating friedreich's ataxia; and GBA1 gene replacement program to treat parkinson's disease. In addition, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Neurocrine Biosciences, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
Voyager Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $4.31 | $4.25 | +0.00% |
12-Nov-25 | $4.31 | $4.25 | -0.12% |
11-Nov-25 | $4.13 | $4.26 | +0.00% |
10-Nov-25 | $4.29 | $4.26 | +0.47% |
07-Nov-25 | $4.10 | $4.24 | +0.47% |
06-Nov-25 | $4.23 | $4.22 | -0.94% |
05-Nov-25 | $4.17 | $4.26 | +2.28% |
FAQs on Voyager Therapeutics, Inc. Share Price
Can I buy Voyager Therapeutics, Inc. shares in India?
What is the share price of Voyager Therapeutics, Inc.?
What is the 5 year returns of Voyager Therapeutics, Inc.?
What are the high & low stock price of Voyager Therapeutics, Inc. today?
What is the 52-week high and low of Voyager Therapeutics, Inc. stock?